Menu
Back to User profile » Prof. Dr. Quan Zhou
Papers published by Prof. Dr. Quan Zhou:
Tizanidine: Advances in Pharmacology & Therapeutics and Drug Formulations
Zhu LL, Wang YH, Zhou Q
Journal of Pain Research 2024, 17:1257-1271
Published Date: 21 March 2024
Exploring the Roles of Nurses in Medication Reconciliation for Older Adults at Hospital Discharge: A Narrative Approach
Zhu LL, Wang YH, Lan MJ, Zhou Q
Clinical Interventions in Aging 2024, 19:367-373
Published Date: 5 March 2024
Progress in Research on the Mechanisms and Interventions of Phlebitis from the Perspective of Vascular Endothelial Cell and Signaling Pathway
Zhu LL, Wang YH, Zhou Q
Journal of Inflammation Research 2023, 16:6469-6481
Published Date: 29 December 2023
The Rate of Infusion Represents an Important Aspect of Administering Anticancer Agents
Lan MJ, Yao DF, Zhu LL, Zhou Q
Risk Management and Healthcare Policy 2023, 16:2531-2541
Published Date: 22 November 2023
Polypill Brings Benefits to Patients with Cardiovascular Disease, Both Improving Medication Adherence and Demonstrating the Concept of Chronotherapy [Letter]
Zhu LL, Zhou Q
Vascular Health and Risk Management 2023, 19:659-660
Published Date: 27 September 2023
Warfarin and Thrombotic Mechanical Aortic Valve – Be Cautious to Avoid Severe Warfarin Drug Interactions in Patients with Suspected Infective Endocarditis after Mechanical Aortic Valve Replacement [Letter]
Zhu LL, Zhou Q
Vascular Health and Risk Management 2023, 19:657-658
Published Date: 25 September 2023
More Smart Use of Direct Oral Anticoagulants in Geriatric Patients [Letter]
Zhu LL, Zhou Q
Drug Design, Development and Therapy 2023, 17:2747-2748
Published Date: 6 September 2023
Effects of Ethanolic Extract of Schisandra sphenanthera on the Pharmacokinetics of Rosuvastatin in Rats
Sun Q, Li L, Zhou Q
Drug Design, Development and Therapy 2022, 16:1473-1481
Published Date: 17 May 2022
What Should Clinicians Do for Older Adults with Polypharmacy and Depression? [Letter]
Zhu LL, Zhou Q
Clinical Interventions in Aging 2022, 17:507-508
Published Date: 19 April 2022
Awareness of Drug–Drug Interaction in Elderly Patients with Osteoarthritis and Depression [Letter]
Zhu LL, Zhou Q
Neuropsychiatric Disease and Treatment 2022, 18:705-706
Published Date: 1 April 2022
Awareness of Genetic Polymorphism in Drug Metabolizing Enzymes and Transporters May Promote Personalized Type 2 Diabetes Management [Letter]
Zhu LL, Zhou Q
Diabetes, Metabolic Syndrome and Obesity 2022, 15:557-558
Published Date: 23 February 2022
Optimal infusion rate in antimicrobial therapy: explosion of evidence in the last five years
Zhu LL, Zhou Q
Infection and Drug Resistance 2018, 11:1105-1117
Published Date: 8 August 2018
Opioid analgesics-related pharmacokinetic drug interactions: from the perspectives of evidence based on randomized controlled trials and clinical risk management
Feng XQ, Zhu LL, Zhou Q
Journal of Pain Research 2017, 10:1225-1239
Published Date: 24 May 2017
Retrospective analysis of non-laboratory-based adverse drug reactions induced by intravenous radiocontrast agents in a Joint Commission International-accredited academic medical center hospital in China
Chen QL, Zhao XY, Wang XM, Lv N, Zhu LL, Xu HM, Zhou Q
Therapeutics and Clinical Risk Management 2017, 13:565-573
Published Date: 26 April 2017
Pharmaceutical interventions by collaboration between staff pharmacists and clinical pharmacists and implementation of Joint Commission International Accreditation Standards on medication use may optimize pharmacotherapy in geriatric patients
Chen M, Zhou Q
Clinical Interventions in Aging 2016, 11:1575-1577
Published Date: 9 November 2016
Is it appropriate regarding patient preference to take Myrtol standardized enteric-coated soft capsules after a meal rather than at fasted state? A food–drug pharmacokinetic interaction study in healthy Chinese volunteers
Zhao TT, Zhu LL, Chen M, Zhou Q
Patient Preference and Adherence 2016, 10:2031-2037
Published Date: 3 October 2016
The association between gastric acid inhibitors and delirium in geriatric inpatients: implications for clinical practice and research
Zhu LL, Zhou Q
Clinical Interventions in Aging 2016, 11:797-799
Published Date: 16 June 2016
Weight-based dosing in medication use: what should we know?
Pan SD, Zhu LL, Chen M, Xia P, Zhou Q
Patient Preference and Adherence 2016, 10:549-560
Published Date: 12 April 2016
Safe medication management and use of narcotics in a Joint Commission International-accredited academic medical center hospital in the People’s Republic of China
Fang X, Zhu LL, Pan SD, Xia P, Chen M, Zhou Q
Therapeutics and Clinical Risk Management 2016, 12:535-544
Published Date: 6 April 2016
The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions
Chen M, Zhou Q
Therapeutics and Clinical Risk Management 2016, 12:351-352
Published Date: 2 March 2016
A stewardship intervention program for safe medication management and use of antidiabetic drugs
Zhao RY, He XW, Shan YM, Zhu LL, Zhou Q
Clinical Interventions in Aging 2015, 10:1201-1212
Published Date: 23 July 2015
The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection
Jin JF, Zhu LL, Chen M, Xu HM, Wang HF, Feng XQ, Zhu XP, Zhou Q
Patient Preference and Adherence 2015, 9:923-942
Published Date: 2 July 2015
Personalized therapeutics of α1-blockers in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
Zhu LL, Feng ZJ, Zhou Q
Clinical Interventions in Aging 2015, 10:621-624
Published Date: 26 March 2015
Pharmacokinetic drug interactions with clopidogrel: updated review and risk management in combination therapy
Wang ZY, Chen M, Zhu LL, Yu LS, Zeng S, Xiang MX, Zhou Q
Therapeutics and Clinical Risk Management 2015, 11:449-467
Published Date: 19 March 2015
Quality improvements in decreasing medication administration errors made by nursing staff in an academic medical center hospital: a trend analysis during the journey to Joint Commission International accreditation and in the post-accreditation era
Wang HF, Jin JF, Feng XQ, Huang X, Zhu LL, Zhao XY, Zhou Q
Therapeutics and Clinical Risk Management 2015, 11:393-406
Published Date: 5 March 2015
Effects of drug pharmacokinetic/pharmacodynamic properties, characteristics of medication use, and relevant pharmacological interventions on fall risk in elderly patients
Chen Y, Zhu LL, Zhou Q
Therapeutics and Clinical Risk Management 2014, 10:437-448
Published Date: 13 June 2014
Personalized therapeutics for levofloxacin: a focus on pharmacokinetic concerns
Gao CH, Yu LS, Zeng S, Huang YW, Zhou Q
Therapeutics and Clinical Risk Management 2014, 10:217-227
Published Date: 27 March 2014
Injection device-related risk management toward safe administration of medications: experience in a university teaching hospital in The People's Republic of China
Zhu LL, Li W, Song P, Zhou Q
Therapeutics and Clinical Risk Management 2014, 10:165-172
Published Date: 17 March 2014
Pharmacokinetic drug–drug interactions between 1,4-dihydropyridine calcium channel blockers and statins: factors determining interaction strength and relevant clinical risk management
Zhou YT, Yu LS, Zeng S, Huang YW, Xu HM, Zhou Q
Therapeutics and Clinical Risk Management 2014, 10:17-26
Published Date: 20 December 2013
Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations
Zhao XY, Xu HM, Zhou Q
Therapeutics and Clinical Risk Management 2013, 9:463-468
Published Date: 25 November 2013
Potential therapeutic hazards due to drug–drug interaction between topically and systemically coadministered medications
Lan MJ, Zhou Q
Therapeutics and Clinical Risk Management 2013, 9:313-317
Published Date: 30 July 2013
Intervention for improving the appropriateness of physician orders for oral medications in geriatric VIP patients during the journey to JCI accreditation
Zhu LL, Zhou Q
Therapeutics and Clinical Risk Management 2013, 9:273-275
Published Date: 28 May 2013
Pharmacokinetic drug interaction profile of omeprazole with adverse consequences and clinical risk management
Li W, Zeng S, Yu LS, Zhou Q
Therapeutics and Clinical Risk Management 2013, 9:259-271
Published Date: 27 May 2013
Safe medication use based on knowledge of information about contraindications concerning cross allergy and comprehensive clinical intervention
Li W, Zhu LL, Zhou Q
Therapeutics and Clinical Risk Management 2013, 9:65-72
Published Date: 26 February 2013
Prescribing practice and evaluation of appropriateness of enteral nutrition in a university teaching hospital
Zhu XP, Zhu LL, Zhou Q
Therapeutics and Clinical Risk Management 2013, 9:37-43
Published Date: 7 February 2013
Appropriateness of administration of nasogastric medication and preliminary intervention
Zhu LL, Xu LC, Wang HQ, Jin JF, Wang HF, Zhou Q
Therapeutics and Clinical Risk Management 2012, 8:393-401
Published Date: 20 November 2012